HEALTHQUARTZ
Chan Zuckerberg Biohub is opening a 4th round of rare disease grants
The Chan Zuckerberg Biohub is launching a fourth round of rare disease grants, having already committed over $150 million across four funding cycles. The organization is also expanding its AI-driven drug repurposing initiatives in collaboration with Every Cure.
Mentioned
Related Signal
Adjacent reporting
- Chan Zuckerberg Initiative's Biohub to open new rare disease funding round
- New effort aims to speed the development of rare-disease treatments
- STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
- STAT+: Astellas treatment offers new hope to a devastated rare disease community
- ORDI honours rare disease champions at Rare Star Awards 2026
- STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs